Dr. Miron-Shatz is the CEO of CureMyWay, an international consulting firm in the health sector. She mainly consults health-focused companies and advertisers, and specializes in finding the levers and barriers to driving behavior change.
Among her clients are some of the world’s largest pharmaceutical companies: Pfizer, Abbvie, Merck, Novartis, Johnson & Johnson, alongside BMS, Boringer-Ingleheim, and others. She has also worked with technological giants, such as NantHealth and Samsung, and with numerous startups, such as Healarium, Glucome, Wisdo (whom she mentored when they were at the Microsoft Ventures accelerator), Telesofia, and many more.
Her academic credibility (over 50 academic papers on medical decision-making and related topics) allows her to work directly with physicians. Accordingly, she has, for example, led advisory boards on the introduction of new drugs, and spoken at medical meetings on topics such as adherence to medication and how it’s affected by regimen.
If you would like to contact Dr. Miron-Shatz to discuss a potential collaboration, you can do so here.
Adherence to medication has been a focus of her work since early on. She did public speaking about it, mostly to physicians, raising awareness and providing tools for increasing patient adherence. She worked with a large pharmaceutical brand to create and revise adherence guidelines as this topic gets diluted through various agencies and budget managers.
Changing prescriber behavior. Prescriber behavior is another angle of consumer behavior, except this time the consumers are physicians—educated, well-intentioned, overworked individuals, whose decision making processes are decidedly human. Dr. Miron-Shatz worked on unveiling physician reasons for prescribing, on physician advisory boards displaying the advantages of new medication, on developing related strategies by advertisers, and on training sales-reps, nationally, in the barriers to prescribing.
Removing barriers to knowledge and action. From imaging results, which patients receive but have difficulty deciphering, to creating a scorecard that highlights what good health entails, Dr. Miron-Shatz designed a deceptively simple, yet medically accurate tool that motivates people to improve health.
Increasing engagement and retention at a wellness website, employee programs and more. Considerable investment goes into programs and websites, such as around diabetes and wellness. Why then is uptake so low, and why are results so disappointing? Dr. Miron-Shatz brought on decision-science-based transformations in the website design, membership tiers, reward structure—the works. The result: increased consumer engagement, as measured by time using the device and number of entries to the website. And, of course, increased revenue and customer satisfaction.
Training marketing executives and teams in consumer behavior. Consumer behavior, which Dr. Miron-Shatz taught at Wharton, remains at the core of how she views consumer interactions. She trained executives and teams from an international cellular brand in the secrets of the trade.
What people are saying
“[Dr. Miron-Shatz] brought her knowledge of the psychology of patients’ motivations, along with behavioral economics into the product design and requirements. Her contributions were both insightful, and very practical after clearly understanding our product constraints. [She] quickly gained the respect and trust of the product development team and became a key contributor to the product. Her professional skills, human-factors skills and knowledge of behavior modification are a big plus for any product team developing patient-facing solutions.”— Vasu Rangadass, President & CEO at L7 Informatics
Working with Dr. Miron Shatz
If you would like to work with Dr. Miron-Shatz, send her a message through the contact page.